Newsletter
Contact
Careers
Calendar
RFP
Français
myGAVI
Donate
Home
About the Alliance
Learn more about GAVI
GAVI's mission
What we do
GAVI's impact
Challenges and opportunities
Healthy girls, healthy women
Gender and immunisation
Why invest in GAVI?
Advocates
GAVI's strategy
Value of vaccination
GAVI's partnership model
GAVI's business model
Global health and development
Governing GAVI
GAVI Board
GAVI Secretariat
GAVI Internal Audit
Programmatic and Finance Policies
Corporate Policies
Types of support
What GAVI offers and how it works
Apply for support
New and underused vaccines support
Human papillomavirus vaccine
Injection safety support
Measles second dose
Meningitis A vaccine
Pentavalent vaccine
Pneumococcal vaccine
Measles-Rubella vaccine
Rotavirus vaccine
Yellow fever vaccine
Immunisation services support
Health Systems Funding Platform
Health system strengthening
Civil society organisation
Country hub
Afghanistan
Albania
Angola
Armenia
Azerbaijan
Bangladesh
Benin
Bhutan
Bolivia
Bosnia & Herzegovina
Burkina Faso
Burundi
Cambodia
Cameroon
Central African Republic (the)
Chad
China
Comoros
Congo
Congo, DR
Côte d’Ivoire
Cuba
Djibouti
Eritrea
Ethiopia
Gambia
Georgia
Ghana
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
India
Indonesia
Kenya
Kiribati
Korea, DPR
Kyrgyzstan
Lao PDR
Lesotho
Liberia
Madagascar
Malawi
Mali
Mauritania
Moldova
Mongolia
Mozambique
Myanmar
Nepal
Nicaragua
Niger
Nigeria
Pakistan
Papua New Guinea
Rwanda
Sao Tome and Principe
Senegal
Sierra Leone
Solomon Islands
Somalia
South Sudan
Sri Lanka
Sudan
Tajikistan
Tanzania, UR
Timor Leste
Togo
Turkmenistan
Uganda
Ukraine
Uzbekistan
Vietnam
Yemen
Zambia
Zimbabwe
Funding & finance
Long-term financial commitments
How GAVI is funded
Key figures: donor contributions & pledges
Donor profiles
Financial reports
GAVI Matching Fund
How it works
Partners
International Finance Facility for Immunisation
Pneumococcal AMC
Results & evidence
Measuring & evaluating performance
Goal-level indicators
Mission indicators
Vaccine goal indicators
Health systems goal indicators
Financing goal indicators
Market-shaping goal indicators
Countries approved for support
Disbursements by country
GAVI's evaluation studies
GAVI first evaluation report
GAVI second evaluation report
GAVI support to CSO evaluation
GAVI-Government of China Hepatitis B vaccination programme
Gender Policy evaluation
IFFIm evaluation
Pneumococcal AMC process and design
Other studies
GAVI Progress reports
Library & news
Search by topic, country and programme
News
Press releases
Statements
Return on investment stories
GAVI features
Eyewitness
GAVI blogs
Audio-visual
Board & committee minutes
GAVI documents
Country documents
Evaluations
Financial reports
Guidelines and forms
Policies
Strategy
Supply and procurement
Publications
Events
You are here:
Library
Audio-visual
Audio-visual
Galleries
Galleries
Brazzaville marks Congo's first pneumococcal vaccinations
Brazzaville marks Congo's first pneumococcal vaccinations
in page functions
At a special ceremony at the Marian Ngoubai Health Centre in Brazzaville, Congo became the 15th sub-Saharan African country to introduce pneumococcal vaccine into its Expanded Programme on Immunisation (EPI).
11 October 2012
Some 200 Congolese mothers watched as children received Congo's first-ever doses of pneumococcal vaccine.
First Lady Antoinette Sassou Nguesso put on a doctor's white coat and vaccinated one child herself. With pneumonia listed as the second cause of death in children aged less than five, pneumococcal vaccine will significantly reduce child mortality.
The Italian Ambassador in Brazzaville, Nicolo Tassoni Estense, addresses the ceremony. Italian funding - together with support from Canada, Norway, the Russian Federation, the UK and the BMGF - was instrumental in setting-up the Advance Market Commitment which encouraged manufacturers to produce large quantities of pneumococal vaccine for developing countries.
Marianne Flach, UNICEF representative to Congo emphasised the critical role of parents in recognising pneumonia in its early stages and immediately taking the infected child to a local health centre for appropriate care.
Support from UNICEF, WHO and GAVI has helped Congo's Health Ministry train vaccination managers and health workers to face the day to day challenges of introducing a new vaccine.
By the end of 2012, the EPI expects to immunise more than 160,000 Congolese children, aged between two and 11 months.
Latest Galleries
Launch ceremony for introduction of pentavalent vaccine - Mogadishu, Somalia
Immunisation in Islamic countries
Madagascar celebrates the introduction of pneumococcal vaccines
Brazzaville marks Congo's first pneumococcal vaccinations
Rotavirus vaccines introduced in health centres in Yemen
The human tragedy and the hope behind Ghana’s historic decision
Model immunisation system sets standard for Mozambique
Seth Berkley in Mozambique March 2012
Chad’s campaign against meningitis A
GAVI’s Matching Fund announcement at WEF
View all latest galleries
modal window here